Dimitrios Panagopoulos

Discovery of small molecule antagonists of human Retinoblastoma Binding Protein 4 (RBBP4)

G. Poda, C. Arrowsmith, M. Schapira, 2021, bioRxiv.

Rational Design and Synthesis of Selective PRMT4 Inhibitors: a New Chemotype for Development of Cancer Therapeutics

C. Arrowsmith, M. Vedadi, M. Szewczyk, 2020, bioRxiv.

Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin.

E. Boix, D. Leonidas, A. Kantsadi, 2015, Bioorganic chemistry.

Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma

A. Edwards, A. Bullock, R. Al-awar, 2020, Journal of medicinal chemistry.

Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics **

C. Arrowsmith, M. Vedadi, M. Szewczyk, 2021, ChemMedChem.

Desferrioxamine attenuates minor lung injury following surgical acute liver failure

M. Lekka, G. Nakos, K. Kalimeris, 2009, European Respiratory Journal.

A mutation in the folA promoter delays adaptation to minimal medium by Escherichia coli K‐12

Dimitrios Panagopoulos, Soo-Hang Wong, M. B. Herrington, 2002, Journal of basic microbiology.

An α-chloroaldehyde-based formal synthesis of eribulin

Guillermo Caballero-García, Robert Britton, H. Zhai, 2023, Nature Communications.